FDA Inspection 1002972 — Broncolin, S.A. de C.V.
The FDA completed an inspection of Broncolin, S.A. de C.V. on February 15, 2017 in Ciudad De Mexico. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- February 15, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Ciudad De Mexico (Mexico)